KeifeRx Alternatives & Competitors
12 companies similar to KeifeRx — KeifeRx is a biopharmaceutical company finding disease-modifying treatments for...
Companies similar to KeifeRx
ProJenX
ProJenX is a clinical-stage biotech developing novel, brain-penetrant MAP4K inhibitors for...
Sitryx
Harnessing the power of cell metabolism to develop groundbreaking disease-modifying therap...
Sling Therapeutics
Focused on late-stage development of an oral small molecule for the treatment of thyroid e...
MethylGene
Harnessing Innovation to Develop Next-Generation Cancer Therapies
Rival Readout
Competing with KeifeRx? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Spero Therapeutics
Clinical-stage biotech company focused on rare diseases and diseases with high unmet need
Antios Therapeutics
Antios Therapeutics is a clinical-stage biopharmaceutical company devoted to developing th...
BerGenBio ASA
Developing Innovative Drugs for Aggressive Diseases
Pharvaris
Pioneering science for patient choice
Samsara Therapeutics
Treating Neurodegenerative Disease by Restoring Autophagy
Laminar Pharma
Biopharmaceutical company performing discovery, rational design and initial clinical devel...
BIORCHESTRA Co., Ltd.
We develop novel RNA-based therapeutics that will be able to bring about a paradigm shift...
About KeifeRx
KeifeRx, founded in 2019, is an emerging biopharmaceutical company headquartered in the United States. The company specializes in developing innovative treatments for neurodegenerative and immune diseases using novel tyrosine kinase inhibitors (TKIs). By focusing on low-dose, orally delivered solutions, KeifeRx address...
development of kinase inhibitors, clinical trials for neurodegenerative disease treatments, collaborative research for drug development
dementia patients, patients with neurodegenerative diseases, healthcare providers in neurology, clinical researchers
Biopharmaceutical, Clinical-stage, Neurodegenerative Diseases, Disease-modifying Treatments, Tyrosine Kinase Inhibitors, Low Dose Therapy, Orally Delivered Medication, Immune Diseases, Drug Discovery, Biotech Innovation, Pharmaceutical Research, Therapeutics Development, Medical Innovation, Biotech Startup
B2B, B2D
Licensing, Product Sales, Performance Based
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around KeifeRx: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at KeifeRx on 11 Mar 2026. The 12 companies listed here were last checked between 19 Jun 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.